Regeneron Seeks Emergency Use Authorization for Antibody Cocktail

THURSDAY, Oct. 8, 2020 — Regeneron Pharmaceuticals Inc. said Wednesday that it is seeking emergency approval from the U.S. Food and Drug Administration for an experimental antibody cocktail given to President Donald Trump shortly after he was…
Source: Topamax